MAXDIO Tablet 160 mg (Valsartan)

Adult dose

1. Essential Hypertension Adults: Recommended initial dose is 80 mg orally once daily. If blood pressure is not adequately controlled, the dose may be increased up to 160 mg daily, with a maximum increase to 320 mg. Elderly (75 years and older): Start at 40 mg orally once daily. Patients with renal impairment: Start at 40 mg orally once daily for creatinine clearance of 10–20 mL/min. Patients with fluid depletion: Start at 40 mg orally once daily.

Child dose

Pediatrics: Safety and efficacy have not been established in children and adolescents under 18 years of age.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. Patients with an allergy to this medication or its components, pregnant women, breastfeeding women, or patients with severe liver or kidney impairment should not take this medication. Elderly patients or those with high potassium levels or liver impairment, patients with cardiac valve disease or cardiovascular disease, should use this medication with caution. Upon initial use, blood pressure may drop sharply; immediate consultation with healthcare professionals is necessary if symptoms such as dizziness or fainting occur. Patients on hemodialysis or on strict salt restrictions, and those taking diuretics may have an increased risk of hypotension and should be particularly cautious. This medication can increase blood potassium levels when taken with other antihypertensives, certain diuretics, or potassium supplements, so it is important to consult a doctor. Occasional side effects such as headache, dizziness, cough, fatigue, and dyspepsia may occur, and consulting a specialist is advisable if abnormal symptoms persist. Caution is needed when driving or operating machinery as dizziness may occur. If this medication is taken during pregnancy, tests may be necessary to check for kidney function and skull condition of the fetus. Safety and efficacy of this medication in children and adolescents have not been established; therefore, it is recommended not to administer it to individuals under 18 years of age. In case of overdose, serious hypotension and decreased consciousness may occur, requiring immediate medical attention, as there is no specific antidote and treatment should be symptomatic. This medication should be kept out of reach of children and should not be transferred to another container.

Serious side effects

Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucous membranes, dyspnea or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• viral infections
• upper respiratory tract infections
• cough
• diarrhea
• fatigue
• rhinitis
• sinusitis
• back pain

This medication should be stored in a sealed container to prevent air and moisture from entering, and it is important to keep it in a cool place below 30 degrees Celsius, avoiding direct sunlight and heat. Proper storage will maintain the medication's efficacy for a longer time and prevent degradation.

Appearance

Grayish-orange oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle